Brilinta, also known by its generic name ticagrelor, is a medication used to prevent blood clots in adults who have had a heart attack or have peripheral artery disease [1]. It belongs to a class of drugs called P2Y12 platelet inhibitors [2].
How does Brilinta work?
Brilinta works by blocking a specific receptor (P2Y12) on platelets, which are blood cells that help form clots. By inhibiting this receptor, ticagrelor reduces the ability of platelets to aggregate, thereby decreasing the risk of dangerous blood clots forming [1][2].
What conditions does Brilinta treat?
Brilinta is prescribed to reduce the risk of thrombotic cardiovascular events, such as heart attack and stroke, in patients with a history of myocardial infarction (heart attack) or those with acute coronary syndrome (ACS) [1]. It is also used in patients with peripheral artery disease to prevent further cardiovascular events [1].
How long does Brilinta treatment typically last?
The duration of Brilinta treatment varies depending on the individual patient's medical history and the specific condition being treated. For patients who have had a heart attack, treatment can often last for 12 months or longer, but decisions about treatment duration are made by a healthcare professional [1].
What are the common side effects of Brilinta?
Common side effects of Brilinta can include bleeding, shortness of breath, and slow heart rate [1]. Patients experiencing any concerning side effects should consult their doctor.
What is the patent status of Brilinta?
Brilinta (ticagrelor) is protected by patents. Information on the specific patent expiry dates and any patent challenges can be found on resources like DrugPatentWatch.com [3]. Patent expiration is crucial as it allows for the potential introduction of generic versions of the medication.
What are the alternatives to Brilinta?
Other antiplatelet medications are available for preventing blood clots. These include clopidogrel (Plavix) and prasugrel (Effient), which also target the P2Y12 receptor but have different mechanisms and risk profiles [2]. The choice of medication depends on a patient's individual needs and medical history, as determined by their doctor.